Anirban Maitra: Targeting the Hippo pathway in cancer by Anwesha Dey and colleagues
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:
“Important Open Access perspective from Anwesha Dey and colleagues, Genentech in Trends in Cancer as this class of agents become relevant in various oncology settings:
Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?”
Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?
Authors: Sayantanee Paul1, Jessica Sims, Trang Pham, Anwesha Dey
Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023